These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33673573)

  • 1. Targeted Physical Therapy Combined with Spasticity Management Changes Motor Development Trajectory for a 2-Year-Old with Cerebral Palsy.
    Stuyvenberg CL; Brown SE; Inamdar K; Evans M; Hsu LY; Rolin O; Harbourne RT; Westcott McCoy S; Lobo MA; Koziol NA; Dusing SC
    J Pers Med; 2021 Feb; 11(3):. PubMed ID: 33673573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenol Versus Botulinum Toxin A Injection in Ambulatory Cerebral Palsy Spastic Diplegia: A Comparative Study.
    Gonnade N; Lokhande V; Ajij M; Gaur A; Shukla K
    J Pediatr Neurosci; 2017; 12(4):338-343. PubMed ID: 29675072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.
    Hoare B; Imms C; Villanueva E; Rawicki HB; Matyas T; Carey L
    Dev Med Child Neurol; 2013 Mar; 55(3):238-47. PubMed ID: 23236956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.
    Choi JY; Kim SK; Park ES
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31717282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best clinical practice in botulinum toxin treatment for children with cerebral palsy.
    Strobl W; Theologis T; Brunner R; Kocer S; Viehweger E; Pascual-Pascual I; Placzek R
    Toxins (Basel); 2015 May; 7(5):1629-48. PubMed ID: 25969944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
    J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the ACTIVLIM-CP questionnaire: measuring global activity performance in children with cerebral palsy.
    Paradis J; Arnould C; Thonnard JL; Houx L; Pons-Becmeur C; Renders A; Brochard S; Bleyenheuft Y
    Dev Med Child Neurol; 2018 Nov; 60(11):1178-1185. PubMed ID: 29869417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
    Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
    Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study.
    Schasfoort F; Dallmeijer A; Pangalila R; Catsman C; Stam H; Becher J; Steyerberg E; Polinder S; Bussmann J
    J Rehabil Med; 2018 Jan; 50(1):22-29. PubMed ID: 28949368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
    Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Review of Unintended Effects After Single-Event Multi-Level Chemoneurolysis With Botulinum Toxin-A and Phenol in Children With Cerebral Palsy.
    Ploypetch T; Kwon JY; Armstrong HF; Kim H
    PM R; 2015 Oct; 7(10):1073-1080. PubMed ID: 26032347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial.
    Olesch CA; Greaves S; Imms C; Reid SM; Graham HK
    Dev Med Child Neurol; 2010 Jan; 52(1):79-86. PubMed ID: 19583742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.
    Yang TF; Chan RC; Chuang TY; Liu TJ; Chiu JW
    J Formos Med Assoc; 1999 Dec; 98(12):832-6. PubMed ID: 10634023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy.
    Dudley RW; Parolin M; Gagnon B; Saluja R; Yap R; Montpetit K; Ruck J; Poulin C; Cantin MA; Benaroch TE; Farmer JP
    J Neurosurg Pediatr; 2013 Aug; 12(2):142-50. PubMed ID: 23713680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.